Physician profile
Cyril E Tabe
NPI 1558457135
$418.85
in general payments reported to CMS, 2019-2025
8 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2020: $77.48 · 2023: $168 · 2024: $128 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $128.15 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.48 | 2020 | |
| Abbott Laboratories | $65.88 | 2023 | Epic |
| Medtronic, INC. | $47.66 | 2023 | Valiant Captivia |
| Edwards Lifesciences Corporation | $41.46 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Hemosphere, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $25.00 | 2019 | |
| Eko Health, INC. | $20.00 | 2025 | |
| Livanova USA, INC. | $13.22 | 2023 | Lifesparc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyril Tabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.